{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:32:58Z","timestamp":1780497178382,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.psychres.2017.12.018","type":"journal-article","created":{"date-parts":[[2017,12,10]],"date-time":"2017-12-10T10:21:10Z","timestamp":1512901270000},"page":"473-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides"],"prefix":"10.1016","volume":"260","author":[{"given":"Aleksandra","family":"Margulska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Koz\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wysoki\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.psychres.2017.12.018_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4088\/JCP.v64n0516","article-title":"Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics","volume":"64","author":"Atmaca","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2017.12.018_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00023210-200822060-00003","article-title":"Pharmacological management of atypical antipsychotic-induced weight gain","volume":"22","author":"Baptista","year":"2008","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.psychres.2017.12.018_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","article-title":"Inhibition of food intake in obese subjects by peptide YY3-36","volume":"349","author":"Batterham","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2017.12.018_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/rp.59.1.267","article-title":"Insulin and leptin as adiposity signals","volume":"59","author":"Benoit","year":"2004","journal-title":"Recent Prog. Horm. Res."},{"issue":"6","key":"10.1016\/j.psychres.2017.12.018_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000176061","article-title":"Accuracy of bioelectrical impedance consumer devices for measurement of body composition in comparison to whole body magnetic resonance imaging and dual X-ray absorptiometry","volume":"1","author":"Bosy-Westphal","year":"2008","journal-title":"Obes. Facts"},{"issue":"7","key":"10.1016\/j.psychres.2017.12.018_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrd.2016.121","article-title":"Obesity: neurotensin inhibition prevents weight gain","volume":"15","author":"Crunkhorn","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.psychres.2017.12.018_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-12-0456","article-title":"Mechanisms in endocrinology: ghrelin: the differences between acyl- and des-acyl ghrelin","volume":"167","author":"Delhanty","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.psychres.2017.12.018_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2007-1004591","article-title":"Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables","volume":"41","author":"Diaz","year":"2008","journal-title":"Pharmacopsychiatry"},{"issue":"14","key":"10.1016\/j.psychres.2017.12.018_bib9","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1073\/pnas.141042198","article-title":"Neurotensin-deficient mice show altered responses to antipsychotic drugs","volume":"98","author":"Dobner","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.psychres.2017.12.018_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2826.2010.02019.x","article-title":"The ghrelin\/obestatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake","volume":"22","author":"Hassouna","year":"2010","journal-title":"J. Neuroendocrinol."},{"issue":"4","key":"10.1016\/j.psychres.2017.12.018_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1871530315666150623092031","article-title":"Weight gain and metabolic changes during treatment with antipsychotics and antidepressants","volume":"15","author":"Himmerich","year":"2015","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"6762","key":"10.1016\/j.psychres.2017.12.018_bib12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"issue":"6680","key":"10.1016\/j.psychres.2017.12.018_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/29993","article-title":"Hypothalamic CART is a new anorectic peptide regulated by leptin","volume":"393","author":"Kristensen","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.psychres.2017.12.018_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2017.12.018_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2014.10.070","article-title":"Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats","volume":"1596","author":"Kursungoz","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.psychres.2017.12.018_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pnpbp.2014.12.001","article-title":"Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin","volume":"58","author":"Lu","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2017.12.018_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/YIC.0b013e328342ce47","article-title":"Abnormal correlation between serum leptin levels and body mass index may predict metabolic dysfunction irrespective of the psychopharmacological treatment","volume":"26","author":"Marquina","year":"2011","journal-title":"Int Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2017.12.018_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.molmet.2013.07.008","article-title":"Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity","volume":"2","author":"Opland","year":"2013","journal-title":"Mol. Metab."},{"issue":"2\u20133","key":"10.1016\/j.psychres.2017.12.018_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2008.08.031","article-title":"Frequency of abnormal correlation between leptin and the body mass index during first and second generation antipsychotic drug treatment","volume":"106","author":"Pena","year":"2008","journal-title":"Schizophr. Res."},{"issue":"3 Suppl 2","key":"10.1016\/j.psychres.2017.12.018_bib20","first-page":"S26","article-title":"Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis","volume":"60","author":"Potvin","year":"2015","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2017.12.018_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.jcp.0000106221.36344.4d","article-title":"Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients","volume":"24","author":"Rostami-Hodjegan","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2017.12.018_bib22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/schbul\/sbm141","article-title":"Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review","volume":"34","author":"Sentissi","year":"2008","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.psychres.2017.12.018_bib23","doi-asserted-by":"crossref","first-page":"G693","DOI":"10.1152\/ajpgi.00536.2003","article-title":"Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide","volume":"286","author":"Stanley","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.psychres.2017.12.018_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0006-8993(98)01349-3","article-title":"Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour","volume":"818","author":"Vrang","year":"1999","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.psychres.2017.12.018_bib25","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1172\/JCI118254","article-title":"Recombinant ob protein reduces feeding and body weight in the ob\/ob mouse","volume":"96","author":"Weigle","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.psychres.2017.12.018_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/WNF.0000000000000062","article-title":"Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapy","volume":"38","author":"Wysokinski","year":"2015","journal-title":"Clin. Neuropharmacol."},{"issue":"2\u20133","key":"10.1016\/j.psychres.2017.12.018_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.schres.2016.07.002","article-title":"Obestatin may be involved in clozapine-induced changes in glucose metabolism","volume":"176","author":"Wysokinski","year":"2016","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.psychres.2017.12.018_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11011-014-9592-6","article-title":"Serum levels of AgRP protein in patients with schizophrenia on clozapine monotherapy","volume":"30","author":"Wysokinski","year":"2015","journal-title":"Metab. Brain Dis."},{"issue":"1\u20132","key":"10.1016\/j.psychres.2017.12.018_bib29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.psychres.2014.08.017","article-title":"Blood serum levels of CART peptide in patients with schizophrenia on clozapine monotherapy","volume":"220","author":"Wysokinski","year":"2014","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.psychres.2017.12.018_bib30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/pcn.12199","article-title":"Serum levels of desacyl ghrelin in patients with schizophrenia on clozapine monotherapy","volume":"68","author":"Wysokinski","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"4\u20135","key":"10.1016\/j.psychres.2017.12.018_bib31","first-page":"169","article-title":"Serum levels of PYY(1-36) peptide in patients with schizophrenia on clozapine monotherapy","volume":"47","author":"Wysokinski","year":"2014","journal-title":"Pharmacopsychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117309721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117309721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:31:01Z","timestamp":1759037461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178117309721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":31,"alternative-id":["S0165178117309721"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2017.12.018","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2017.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}